aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
GenePeeks Inc, founded by Anne Morriss and Lee Silver, is a genetic research company based in New York City. The company's core mission is to reduce the risk of heritable diseases by simulating the genetic recombination of prospective parents' DNA. GenePeeks offers a product called Matchright, which digitally weaves together the DNA of two individuals to predict potential genetic disorders in their future children. This service is aimed at prospective parents looking to understand and mitigate genetic risks.
Notable figures affiliated with GenePeeks include its founders, Anne Morriss and Lee Silver, who have backgrounds in genetic research and software development. The company has made significant strides in the field of genetic risk assessment, providing a valuable tool for those concerned about inherited diseases. GenePeeks' innovative approach has had a meaningful impact on genetic counseling and reproductive planning, helping many prospective parents make informed decisions about their future families.
Operating Status
Closed
Ownership Type(s)
Venture Capital
Main Product(s)
Genetic Testing
Technology
Analytics, AI
Tags
Biotech, Healthtech
Model Types
Data Information, Software
Revenue Type(s)
Transactional
Customer Type(s)
Consumers
Geographic Exposure
United States
When was GenePeeks founded?
GenePeeks was founded in 2009.
Where is GenePeeks's headquarters located?
GenePeeks's headquarters is located in New York City, NY, US.
When was GenePeeks's last funding round?
GenePeeks's most recent funding round was for $4.5M (USD) in January 2017.
How many employees does GenePeeks have?
GenePeeks has 30 employees as of Feb 11, 2024.
How much has GenePeeks raised to-date?
As of July 05, 2023, GenePeeks has raised a total of $28.8M (USD) since Jan 25, 2017.
Add Comparison
Total Raised to Date
$28.8M
USD
Last Update Jan 25, 2017
Last Deal Details
$4.5M
USD
Jan 25, 2017
Debt Financing
Total Employees Over Time
30
As of Feb 2024
GenePeeks Address
175 Varick St
New York City,
New York
10014
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts